Skip to main content
Erschienen in:

20.02.2020 | Colorectal Cancer

Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study

verfasst von: Syed Nabeel Zafar, MBBS, MPH, Chung-Yuan Hu, MPH, PhD, Rebecca A. Snyder, MD, MPH, Amanda Cuddy, MPH, Y. Nancy You, MD, MHSc, Lisa M. Lowenstein, PhD, Robert J. Volk, PhD, George J. Chang, MD, MS

Erschienen in: Annals of Surgical Oncology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Several factors can affect the risk of recurrence after curative resection of colorectal cancer (CRC). We aimed to develop a risk model for recurrence after definitive treatment of Stage I–III CRC using data from a nationally representative database and to develop an individualized web-based risk calculator.

Methods

A random sample of patients who underwent resection for Stage I–III CRC between 2006 and 2007 at Commission on Cancer (CoC) accredited centers were included. Primary data regarding first recurrence was abstracted from medical records and merged with the National Cancer Database. Multivariable cox regression analysis was used to test for factors associated with cancer recurrence, stratified by stage. Model performance was tested by c statistic and calibration plots. Hazard Ratios were utilized to develop an individualized web-based recurrence prediction tool.

Results

A total of 8249 patients from 1175 CoC centers were included. Of these, 1656 (20.1%) patients had a recurrence during 5 years of follow-up. Median time to recurrence was 16 months. The final predictive models displayed excellent discrimination and calibration with concordance indexes of 0.7. The online calculator included 12 variables, including tumor site, stage, time since surgery, and surveillance intensity. Output is displayed numerically and graphically with an icon array.

Conclusions

Using primarily abstracted recurrence data from a random sample of patients treated for CRC at CoC accredited centers across the United States, we successfully created an individualized CRC recurrence risk assessment tool. This web-based calculator can be used by physicians and patients in shared decision making to guide management discussions.

Trial Registration

ClinicalTrials.gov Registration Number: NCT02217865.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Kawai K, Nozawa H, Hata K, et al. Nomogram predicting survival after recurrence in patients with stage I to III colon cancer: a nationwide multicenter study. Dis Colon Rectum. 2018;61(9):1053–62.CrossRef Kawai K, Nozawa H, Hata K, et al. Nomogram predicting survival after recurrence in patients with stage I to III colon cancer: a nationwide multicenter study. Dis Colon Rectum. 2018;61(9):1053–62.CrossRef
3.
Zurück zum Zitat Liska D, Stocchi L, Karagkounis G, et al. Incidence, patterns, and predictors of locoregional recurrence in colon cancer. Ann Surg Oncol. 2017;24(4):1093–9.CrossRef Liska D, Stocchi L, Karagkounis G, et al. Incidence, patterns, and predictors of locoregional recurrence in colon cancer. Ann Surg Oncol. 2017;24(4):1093–9.CrossRef
4.
Zurück zum Zitat Okamura R, Hida K, Nishizaki D, Sugihara K, Sakai Y. Proposal of a stage-specific surveillance strategy for colorectal cancer patients: a retrospective analysis of Japanese large cohort. Eur J Surg Oncol. 2018;44(4):449–55.CrossRef Okamura R, Hida K, Nishizaki D, Sugihara K, Sakai Y. Proposal of a stage-specific surveillance strategy for colorectal cancer patients: a retrospective analysis of Japanese large cohort. Eur J Surg Oncol. 2018;44(4):449–55.CrossRef
5.
Zurück zum Zitat Osterman E, Glimelius B. Recurrence risk after up-to-date colon cancer staging, surgery, and pathology: analysis of the entire Swedish population. Dis Colon Rectum. 2018;61(9):1016–25.CrossRef Osterman E, Glimelius B. Recurrence risk after up-to-date colon cancer staging, surgery, and pathology: analysis of the entire Swedish population. Dis Colon Rectum. 2018;61(9):1016–25.CrossRef
6.
Zurück zum Zitat Rose J, Augestad KM, Cooper GS. Colorectal cancer surveillance: what’s new and what’s next. World J Gastroenterol. 2014;20(8):1887–97.CrossRef Rose J, Augestad KM, Cooper GS. Colorectal cancer surveillance: what’s new and what’s next. World J Gastroenterol. 2014;20(8):1887–97.CrossRef
7.
Zurück zum Zitat Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97(11):1638–45.CrossRef Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg. 2010;97(11):1638–45.CrossRef
8.
Zurück zum Zitat Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008;26(3):380–5.CrossRef Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008;26(3):380–5.CrossRef
9.
Zurück zum Zitat Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ Can Med Assoc J. 1995;152(9):1423–33. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ Can Med Assoc J. 1995;152(9):1423–33.
10.
Zurück zum Zitat Nielsen-Bohlman L, Panzer AM. Health literacy: a prescription to end confusion. Washington, DC: Institute of Medicine/National Academies Press; 2004. Nielsen-Bohlman L, Panzer AM. Health literacy: a prescription to end confusion. Washington, DC: Institute of Medicine/National Academies Press; 2004.
12.
Zurück zum Zitat Snyder RA, Hu CY, Cuddy A, et al. Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA. 2018;319(20):2104–15.CrossRef Snyder RA, Hu CY, Cuddy A, et al. Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA. 2018;319(20):2104–15.CrossRef
13.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th ed. New York: Springer; 2010. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th ed. New York: Springer; 2010.
15.
Zurück zum Zitat Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91(7):1229–35.CrossRef Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91(7):1229–35.CrossRef
16.
Zurück zum Zitat Cox D, Reid N. Analysis of survival data. New York: Routledge; 1984. Cox D, Reid N. Analysis of survival data. New York: Routledge; 1984.
17.
Zurück zum Zitat Zhang MJ. Cox proportional hazards regression models for survival data in cancer research. Cancer Treat Res. 2002;113:59–70.CrossRef Zhang MJ. Cox proportional hazards regression models for survival data in cancer research. Cancer Treat Res. 2002;113:59–70.CrossRef
18.
Zurück zum Zitat Lee YT. Local and regional recurrence of carcinoma of the colon and rectum: I. Tumour-host factors and adjuvant therapy. Surg Oncol. 1995;4(6):283–93. Lee YT. Local and regional recurrence of carcinoma of the colon and rectum: I. Tumour-host factors and adjuvant therapy. Surg Oncol. 1995;4(6):283–93.
19.
Zurück zum Zitat Lee YT. Local and regional recurrence of carcinoma of the colon and rectum: II. Factors relating to operative technique. Surg Oncol. 1996;5(1):1–13. Lee YT. Local and regional recurrence of carcinoma of the colon and rectum: II. Factors relating to operative technique. Surg Oncol. 1996;5(1):1–13.
20.
Zurück zum Zitat Elferink MA, Visser O, Wiggers T, et al. Prognostic factors for locoregional recurrences in colon cancer. Ann Surg Oncol. 2012;19(7):2203–11.CrossRef Elferink MA, Visser O, Wiggers T, et al. Prognostic factors for locoregional recurrences in colon cancer. Ann Surg Oncol. 2012;19(7):2203–11.CrossRef
21.
Zurück zum Zitat Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol. 2001;19(18):3895–902.CrossRef Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol. 2001;19(18):3895–902.CrossRef
22.
Zurück zum Zitat Berian JR, Cuddy A, Francescatti AB, et al. A systematic review of patient perspectives on surveillance after colorectal cancer treatment. J Cancer Survivorship Res Pract. 2017;11(5):542–52.CrossRef Berian JR, Cuddy A, Francescatti AB, et al. A systematic review of patient perspectives on surveillance after colorectal cancer treatment. J Cancer Survivorship Res Pract. 2017;11(5):542–52.CrossRef
23.
Zurück zum Zitat Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor’s perspective. J Clin Oncol. 2011;29(10):1280–9.CrossRef Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor’s perspective. J Clin Oncol. 2011;29(10):1280–9.CrossRef
24.
Zurück zum Zitat Kattan MW, Zelefsky MJ, Kupelian PA, et al. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol. 2003;21(24):4568–71.CrossRef Kattan MW, Zelefsky MJ, Kupelian PA, et al. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol. 2003;21(24):4568–71.CrossRef
25.
Zurück zum Zitat Hung YT, Wu CF, Liang TH, et al. Developing a decision-aid website for breast cancer surgery: an action research approach. J Med Internet Res. 2019;21(2):e10404.CrossRef Hung YT, Wu CF, Liang TH, et al. Developing a decision-aid website for breast cancer surgery: an action research approach. J Med Internet Res. 2019;21(2):e10404.CrossRef
26.
Zurück zum Zitat Gornick MC, Kurian AW, An LC, et al. Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial. Cancer. 2018;124(20):4000–9.CrossRef Gornick MC, Kurian AW, An LC, et al. Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial. Cancer. 2018;124(20):4000–9.CrossRef
27.
Zurück zum Zitat Volk RJ, Linder SK, Leal VB, et al. Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. Prevent Med. 2014;62:60–3.CrossRef Volk RJ, Linder SK, Leal VB, et al. Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. Prevent Med. 2014;62:60–3.CrossRef
28.
Zurück zum Zitat Lowenstein LM, Deyter GMR, Nishi S, Wang T, Volk RJ. Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs. Transl lung Cancer Res. 2018;7(3):254–71.CrossRef Lowenstein LM, Deyter GMR, Nishi S, Wang T, Volk RJ. Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs. Transl lung Cancer Res. 2018;7(3):254–71.CrossRef
29.
Zurück zum Zitat Spatz ES, Krumholz HM, Moulton BW. Prime time for shared decision making. JAMA. 2017;317(13):1309–10.CrossRef Spatz ES, Krumholz HM, Moulton BW. Prime time for shared decision making. JAMA. 2017;317(13):1309–10.CrossRef
30.
Zurück zum Zitat Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Systematic Rev. 2017;4:CD001431. Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Systematic Rev. 2017;4:CD001431.
31.
Zurück zum Zitat Volk RJ, Linder SK, Lopez-Olivo MA, et al. Patient decision aids for colorectal cancer screening: a systematic review and meta-analysis. Am J Prevent Med. 2016;51(5):779–91.CrossRef Volk RJ, Linder SK, Lopez-Olivo MA, et al. Patient decision aids for colorectal cancer screening: a systematic review and meta-analysis. Am J Prevent Med. 2016;51(5):779–91.CrossRef
32.
Zurück zum Zitat Honda M, Oba K, Akiyoshi T, et al. Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials. Oncotarget. 2017;8(58):99150–60.CrossRef Honda M, Oba K, Akiyoshi T, et al. Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials. Oncotarget. 2017;8(58):99150–60.CrossRef
33.
Zurück zum Zitat Peng J, Ding Y, Tu S, et al. Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers. PloS One. 2014;9(8):e106344.CrossRef Peng J, Ding Y, Tu S, et al. Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers. PloS One. 2014;9(8):e106344.CrossRef
34.
Zurück zum Zitat Valentini V, van Stiphout RG, Lammering G, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163–72.CrossRef Valentini V, van Stiphout RG, Lammering G, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163–72.CrossRef
35.
Zurück zum Zitat Kawai K, Sunami E, Yamaguchi H, et al. Nomograms for colorectal cancer: a systematic review. World J Gastroenterol. 2015;21(41):11877–86.CrossRef Kawai K, Sunami E, Yamaguchi H, et al. Nomograms for colorectal cancer: a systematic review. World J Gastroenterol. 2015;21(41):11877–86.CrossRef
36.
Zurück zum Zitat Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–51.CrossRef Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–51.CrossRef
Metadaten
Titel
Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study
verfasst von
Syed Nabeel Zafar, MBBS, MPH
Chung-Yuan Hu, MPH, PhD
Rebecca A. Snyder, MD, MPH
Amanda Cuddy, MPH
Y. Nancy You, MD, MHSc
Lisa M. Lowenstein, PhD
Robert J. Volk, PhD
George J. Chang, MD, MS
Publikationsdatum
20.02.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 8/2020
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08238-7

Neu im Fachgebiet Chirurgie

Op.-Entscheidung bei Divertikulitis: Lebensqualität zählt!

Soll man Menschen, die schon mehrfach schmerzhafte Divertikulitisepisoden durchgemacht haben, eine Op. anbieten? Ein Team aus Helsinki rät, dies von der Lebensqualität abhängig zu machen.

Akute Cholezystitis bei multimorbiden Älteren: Operation nicht sofort ausschließen!

Bei älteren, multimorbiden Menschen mit akuter Cholezystitis wird eine Operation häufig nicht erwogen. Eine Studie aus Philadelphia zeigt nun jedoch, dass auch diese Patientinnen und Patienten von einer chirurgischen Therapie profitieren können.

Was geschehen muss, damit Prähabilitation in die Leitlinien kommt

Eine Prähabilitation vor einem viszeralchirurgischen Eingriff ist Experten zufolge äußerst sinnvoll, dennoch wird sie in Leitlinien derzeit nicht empfohlen. Beim DCK erklärte Prof. Tim Vilz aus Bonn, woran das liegt und was benötigt wird, um die Situation zu ändern.

Thoracic-Outlet-Syndrom nur in Ausnahmefällen operieren!

Das Thoracic-Outlet-Syndrom erfordert nur in ganz bestimmten Fällen ein operatives Vorgehen. Beim DCK wurde vor schwerwiegenden Komplikationen des anspruchsvollen Eingriffs gewarnt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.